Lexeo Therapeutics Inc (LXEO)

EBITDA Margin

-11650.47%

TTM · Period ending:

LXEO logo

LXEO EBITDA Margin

Latest reported-11650.47%
LXEO TTM EBITDA Margin (-8883.37% → -11650.47%)
High-resolution chart · PNG

LXEO ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Lexeo Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-11,650.4708%
-11,215.6165%
-8,883.3696%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.